Zhende Medical Co., Ltd. (SHA:603301)

Zhende Medical Revenue

Zhende Medical had revenue of 1.22B CNY in the quarter ending June 30, 2026, with 10.37% growth. This brings the company's total for the last twelve months to 4.45B, up 3.05% year-over-year. In the year 2025, Zhende Medical had annual revenue of 4.33B with 1.54% growth. That makes Zhende Medical the 9,621st largest company in the world by revenue and 1,530th in China.

• Revenue (ttm): 4.45B
• Revenue Growth: +3.05%
• P/S Ratio: 4.74
• Revenue / Employee: 563.09K
• Employees: 7,909
• Market Cap: 21.12B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Surgical Infection Control 1.88B 43.3%
• Basic Care 878.34M 20.3%
• Ostomy and Modern Wound Care 758.28M 17.5%
• Compression Therapy and Immobilization 487.42M 11.3%
• Infection Control Protection 306.11M 7.1%
• Other 23.05M 0.5%

By Geography

Chart

• Overseas 2.68B 62.0%
• China 1.65B 38.0%

Fiscal year ended Dec 31, 2025 See the full Zhende Medical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.33B	65.71M	1.54%
Dec 31, 2024	4.26B	136.84M	3.32%
Dec 31, 2023	4.13B	-2.01B	-32.76%
Dec 31, 2022	6.14B	1.05B	20.54%
Dec 31, 2021	5.09B	-5.31B	-51.04%

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 24, 2026

Data Sources Report a data error